共 50 条
- [41] TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion MutationsMOLECULAR CANCER THERAPEUTICS, 2018, 17 (08) : 1648 - 1658Hasako, ShinichiTerasaka, MikiAbe, NaomiUno, TakaoOhsawa, HirokazuHashimoto, AkihiroFujita, RyotoTanaka, KenjiOkayama, TakashigeWadhwa, RenuMiyadera, KazutakaAoyagi, YoshimiYonekura, KazuhikoMatsuo, Kenichi
- [42] CLINICAL, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF EGFR EXON 20 INSERTION MUTATIONS IN LUNG CANCERJOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S355 - S355Costa, Daniel B.Yasuda, HiroyukiPark, EunyoungYun, Cai-HongHuberman, Mark S.Oxnard, Geoffrey R.Sequist, Lecia V.Riely, GregorySoo, RossEck, Michael J.Kobayashi, Susumu S.
- [43] Discovery of selective and potent EGFR kinase inhibitors for exon20 insertion mutationsMOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)Kim, SunghwanLee, YounhoKim, HwanKang, JuheeSeok, JiyoonSeo, Kyung-AhAhn, JaeyoungKang, Hee-BumLee, Sun-HwaSon, Jung BeomChoi, Hwan GeunKim, Nam Doo
- [44] Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion MutationsJOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 3700 - 3748Mccoull, WilliamThomson, ClareBraybrooke, ErinChan, ChristinaColclough, NicolaGonzalez, Miguel A. CortesCosulich, SabinaDavies, Nichola L.Floc'h, NicolasGreenwood, RyanHargreaves, DavidHuang, PengHunt, Thomas A.Johnson, TonyJohnstrom, PeterKettle, Jason G.Kondrashov, MikhailKostomiris, Demetrios H.Li, SongleiLister, AndrewMartin, ScottMckerrecher, DarrenMclean, NevilleNissink, J. Willem M.Orme, Jonathan P.Orwig, PaigePacker, Martin J.Pearson, StuartQin, LinaFelisberto-Rodrigues, CatarinaSavoca, AdrianaSchou, MagnusStokes, StephenSwaih, Aisha M.Talbot, SaraTucker, Michael J.Ward, Richard A.Wadforth, EmmaWang, ChunliWilson, JoanneYang, Yawen
- [45] Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion MutationsLUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 61 - 65Zhang, Shannon S.Zhu, Viola W.
- [46] EGFR exon 20 insertion mutations in non-small cell lung cancerTRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991Wang, FenfangLi, ChenghuiWu, QihuanLu, Hongyang
- [47] Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion MutationsJOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S634 - S634Lv, D.Lin, L.Wu, X.Yan, S.Ge, H.Yan, Z.Wang, G.
- [48] Structure optimization and discovery of novel compound for the treatment of insertion mutations within exon 20 of EGFR and HER2BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 81Cui, YetongWang, RuonanWei, YujiaoHou, FeiLi, HaixiJiang, YuruiSun, YueFu, ShushuZuo, LinaWang, XiaojiLi, MingLi, JinlingLiu, NingZhang, KunWei, MingmingYang, Guang
- [49] Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion MutationsONCOTARGETS AND THERAPY, 2020, 13 : 9753 - 9757Lin, LingWu, XiaomaiYan, ShuangquanZhu, YefeiYan, ZhengqingLv, DongqingGe, Hongfei
- [50] EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical ScenariosCELLS, 2021, 10 (12)Kobayashi, Ikei S.Viray, HollisRangachari, DeepaKobayashi, Susumu S.Costa, Daniel B.